Kenvue Inc.
One of the world's largest pure-play consumer health companies, Kenvue makes everyday brands most people already know — Tylenol and Zyrtec for self-care, Neutrogena and Aveeno for skin, and Listerine and BAND-AID for everyday essentials — sold in more than 165 countries. It was spun off from Johnson & Johnson in 2023, and its name blends a Scottish word meaning "knowledge" with "view," chosen to suggest deep consumer insight. The name is pronounced "ken-view."
Granted 13.9K
Granted 11.3K
Granted 8.5K
Granted 4.3K · Sold 3.7K
Granted 24.2K
Sold 38.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Lawson CarltonGroup President EMEA & LA · 2 transactions | +14.2% | 111.4K | 13.9K | — | — |
| Stevens MeredithChief Operations Officer · 6 transactions | +3% | 93.6K | 11.3K | — | — |
| Alvarado LuaniChief People Officer · 6 transactions | +10.5% | 61.8K | 8.5K | — | — |
| Howlett HeatherCFO & CAO · 5 transactions | -4.6% | 29.3K | 4.3K | — | 3.7K |
| Curado Gomes de Lemos LeonardoGroup President LATAM · 2 transactions | — | 17.1K | 24.2K | — | — |
| Orlando MatthewGeneral Counsel · 1 transaction | -100% | 0 | — | — | 38.5K |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last 6 months: -42.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.